Literature DB >> 2831781

Characterization of corticosterone feedback regulation of ACTH secretion.

M F Dallman1, S F Akana, L Jacobson, N Levin, C S Cascio, J Shinsako.   

Abstract

Adrenalectomy-induced increases in ACTH secretion in rats are returned to normal by an action of corticosterone on the brain, not on the pituitary. Five days after adrenalectomy with constant steroid replacement, the concentration of free corticosterone in plasma which reduces plasma ACTH by 50% is approximately 0.8 nM. By contrast, the concentration of free plasma corticosterone required for 50% reduction of thymus wet weight or plasma transcortin concentration (both targets for glucocorticoid action) is about 4.5 nM. These results suggested that the inhibition of ACTH by corticosterone might be mediated by association of the steroid with high affinity, type I corticosteroid receptors, whereas the inhibition of thymus weight and transcortin might be mediated by association of the steroid with lower affinity, type II receptors. The results of studies comparing the ability of corticosterone, dexamethasone and aldosterone to inhibit adrenalectomy-induced ACTH secretion support the hypothesis that basal ACTH secretion in rats is mediated by association of corticosterone with type I receptors.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2831781     DOI: 10.1111/j.1749-6632.1987.tb24976.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  32 in total

1.  Concentration dependent actions of glucocorticoids on neuronal viability and survival.

Authors:  István M Abrahám; Peter Meerlo; Paul G M Luiten
Journal:  Dose Response       Date:  2006-06-20       Impact factor: 2.658

2.  Caffeine stimulation of cortisol secretion across the waking hours in relation to caffeine intake levels.

Authors:  William R Lovallo; Thomas L Whitsett; Mustafa al'Absi; Bong Hee Sung; Andrea S Vincent; Michael F Wilson
Journal:  Psychosom Med       Date:  2005 Sep-Oct       Impact factor: 4.312

3.  Sex differences in activation of the hypothalamic-pituitary-adrenal axis by methamphetamine.

Authors:  Damian G Zuloaga; Lance A Johnson; Maayan Agam; Jacob Raber
Journal:  J Neurochem       Date:  2014-02-10       Impact factor: 5.372

Review 4.  A users guide to HPA axis research.

Authors:  Robert L Spencer; Terrence Deak
Journal:  Physiol Behav       Date:  2016-11-18

5.  Effects of acute restraint-induced stress on glucocorticoid receptors and brain-derived neurotrophic factor after mild traumatic brain injury.

Authors:  G S Griesbach; J Vincelli; D L Tio; D A Hovda
Journal:  Neuroscience       Date:  2012-03-15       Impact factor: 3.590

6.  Angiotensin II receptors in paraventricular nucleus, subfornical organ, and pituitary gland of hypophysectomized, adrenalectomized, and vasopressin-deficient rats.

Authors:  E Castrén; J M Saavedra
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

Review 7.  Coexisting peptides in hypothalamic neuroendocrine systems: some functional implications.

Authors:  C A Bondy; M H Whitnall; L S Brady; H Gainer
Journal:  Cell Mol Neurobiol       Date:  1989-12       Impact factor: 5.046

Review 8.  Plasticity of the stress response early in life: mechanisms and significance.

Authors:  Aniko Korosi; Tallie Z Baram
Journal:  Dev Psychobiol       Date:  2010-11       Impact factor: 3.038

9.  Effects of inhibiting neonatal methamphetamine-induced corticosterone release in rats by adrenal autotransplantation on later learning, memory, and plasma corticosterone levels.

Authors:  Curtis E Grace; Tori L Schaefer; Devon L Graham; Matthew R Skelton; Michael T Williams; Charles V Vorhees
Journal:  Int J Dev Neurosci       Date:  2010-02-23       Impact factor: 2.457

Review 10.  The long-term impact of early life pain on adult responses to anxiety and stress: Historical perspectives and empirical evidence.

Authors:  Nicole C Victoria; Anne Z Murphy
Journal:  Exp Neurol       Date:  2015-07-22       Impact factor: 5.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.